These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 554810

  • 21. In vitro antibacterial activity of NB-003 against Propionibacterium acnes.
    Pannu J, McCarthy A, Martin A, Hamouda T, Ciotti S, Ma L, Sutcliffe J, Baker JR.
    Antimicrob Agents Chemother; 2011 Sep; 55(9):4211-7. PubMed ID: 21746943
    [Abstract] [Full Text] [Related]

  • 22. Antimicrobial susceptibilities of Propionibacterium acnes isolated from patients with acne vulgaris.
    Ishida N, Nakaminami H, Noguchi N, Kurokawa I, Nishijima S, Sasatsu M.
    Microbiol Immunol; 2008 Dec; 52(12):621-4. PubMed ID: 19120976
    [Abstract] [Full Text] [Related]

  • 23. Activity of the novel macrolide BAL19403 against ribosomes from erythromycin-resistant Propionibacterium acnes.
    Dreier J, Amantea E, Kellenberger L, Page MG.
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4361-5. PubMed ID: 17923495
    [Abstract] [Full Text] [Related]

  • 24. Effects of topical erythromycin on aerobic and anaerobic surface flora.
    Bernstein JE, Shalita AR.
    Acta Derm Venereol; 1980 Dec; 60(6):537-9. PubMed ID: 6162344
    [Abstract] [Full Text] [Related]

  • 25. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
    Abeck D.
    MMW Fortschr Med; 2003 Dec 18; 145(51-52):29. PubMed ID: 14974325
    [No Abstract] [Full Text] [Related]

  • 26. Antimicrobiol susceptibility of Propinibacterium acnes and related microbial species.
    Hoeffler U, Ko HL, Pulverer G.
    Antimicrob Agents Chemother; 1976 Sep 18; 10(3):387-94. PubMed ID: 984781
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Have extemporaneously compounded topical antibiotics a place? The clindamycin saga.
    Mills OH, Kligman AM.
    Hawaii Med J; 1982 Nov 18; 41(11):416-9. PubMed ID: 7161090
    [No Abstract] [Full Text] [Related]

  • 32. Resveratrol inhibition of Propionibacterium acnes.
    Docherty JJ, McEwen HA, Sweet TJ, Bailey E, Booth TD.
    J Antimicrob Chemother; 2007 Jun 18; 59(6):1182-4. PubMed ID: 17449884
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Sensitivity of enteropathogenic Escherichia coli 0124 to some antibiotics (based on data from a hospital for communicable diseases)].
    Garanin BA.
    Antibiotiki; 1970 Mar 18; 15(3):251-3. PubMed ID: 4911266
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
    Kurokawa I, Nishijima S, Kawabata S.
    Eur J Dermatol; 1999 Mar 18; 9(1):25-8. PubMed ID: 9920982
    [Abstract] [Full Text] [Related]

  • 37. Anti-inflammatory effects of erythromycin and tetracycline on Propionibacterium acnes induced production of chemotactic factors and reactive oxygen species by human neutrophils.
    Jain A, Sangal L, Basal E, Kaushal GP, Agarwal SK.
    Dermatol Online J; 2002 Oct 18; 8(2):2. PubMed ID: 12546757
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Inhibition of lipase production in Propionibacterium acnes by sub-minimal-inhibitory concentrations of tetracycline and erythromycin.
    Webster GF, McGinley KJ, Leyden JJ.
    Br J Dermatol; 1981 Apr 18; 104(4):453-7. PubMed ID: 6786318
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.